A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.

One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

US President Donald Trump kicked off his second term with a series of directives aimed at the US National Institutes of ...

Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

There is growing enthusiasm about China’s potential to speed up drug development with AI. And companies outside the country ...

Middle molecules with a molecular weight of more than 1,000 are difficult to synthesize due to multiple steps and time-consuming nature, demanding the development of a new approach that can overcome ...

The government of Japan has approved a draft revision of a law aimed at strengthening the development of new drugs in the ...

Aardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.

Experts say A.I. is transforming the industry. Traditionally, drug development is expensive - often taking billions of dollars and years of experimentation and trials. And there is no guarantee ...